Goodbody Health Limited announced that it has partnered with Datar Cancer Genetics ("Datar") a liquid biopsy company to offer its innovative Circulating Tumor Cell (CTC) based multi-cancer screening solution Trucheck in the UK.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -66.67% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.67% | 3.65K | |
+43.33% | 6.3B | |
-16.78% | 4.44B | |
-6.93% | 3.27B | |
+3.89% | 3.16B | |
-0.88% | 2.58B | |
+46.64% | 1.96B | |
-5.34% | 1.73B | |
+1.60% | 1.68B | |
-7.31% | 1.63B |
- Stock Market
- Equities
- GDBYF Stock
- News Goodbody Health Limited
- Goodbody Health Limited Partners with Datar to Offer Innovative Cancer Screening